02 Sept 2019
Type 2 diabetes treatment, dapagliflozin, is also effective for reducing the risk of heart failure, according to research presented at the European Society of Cardiology conference in Paris.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024